from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2666/-

LFCtreatmentdescriptionclass of inhibitor

0.275

Amikacinug/mL Amikacintranslation

0.344

Cap5-10ug/mL Capreomycintranslation

0.556

Rox10-50 ug/mL Roxithromycintranslation

0.239

SM2-5 ug/mL Streptomycintranslation

0.043

Tet5-10 ug/mL Tetracyclinetranslation

0.811

Rif0.2-5ug/mL Rifampicintranscription

0.224

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.614

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.465

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.014

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.496

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.352

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.031

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.211

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.152

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.657

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.053

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.229

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.630

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.136

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.048

KCN5-20 ug/mL Potassium cyaniderespiration

-1.157

NaN30.2-2 mM Sodium aziderespiration

-0.043

Nigericin50 uM Nigericinrespiration

0.520

TRC10-150 ug/mL Triclosanrespiration

0.306

TRZ10-25 ug/mL Thioridazinerespiration

4.153

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.239

menadione6-10 ug/mL Menadionerespiration

-0.017

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.083

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.611

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.093

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.981

NRP_1Non-replicating persistence stage 1dosRassociated

0.920

Amp0.2mg/mL AmpicillincellWall

0.363

Cephalexin20-100 ug/mL CephalexincellWall

-0.346

Cerulenin0.32-5 ug/mL CerulenincellWall

0.015

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.122

EMB10-20 ug/mL EthambutolcellWall

-0.212

Eta12-40 ug/mL EthionamidecellWall

-0.336

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.309

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.220

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.197

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.044

BZA0.12 mg/mL BenzamidearomaticAmides

-0.115

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.219

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.183

H2O24 mM hydrogen peroxideDNAdamaging

0.044

Levo10 ug/mL LevofloxacinDNAdamaging

-0.392

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.600

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.135

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.622

UVUV-irradiationDNAdamaging

-0.121

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.017

Antimycin12.5-50 ug/mL Antimycin A?

0.055

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.405

PA_110-50 ug/mL Antitubercular compound PA-1?

0.217

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.887

PA8240.2-2 ug/mL PA-824?

0.215

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.290

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.583

Verapamil50 uM Verapamil?

0.025

mercaptoethanol2 mM 2-Mercaptoethanol?

0.637

methoxatin10-20 ug/mL Methoxatin?